Compounds > voriconazole
Page last updated: 2024-08-25

voriconazole and Adverse Drug Event

voriconazole has been researched along with Adverse Drug Event in 38 studies

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (5.26)29.6817
2010's26 (68.42)24.3611
2020's10 (26.32)2.80

Authors

AuthorsStudies
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Deaciuc, AG; Dennis, EK; Dwoskin, LP; Garneau-Tsodikova, S; Green, KD; Kwiatkowski, S; Ngo, HX; Shrestha, SK; Thamban Chandrika, N; Watt, DS1
Argaud, L; Aubrun, F; Bienvenu, AL; Chidiac, C; Fellahi, JL; Gagnieu, MC; Goutelle, S; Leboucher, G; Leclerc, V; Menotti, J; Parant, F; Piriou, V; Plesa, A; Pradat, P; Richard, JC; Rimmelé, T; Tod, M1
Akcam, FZ; Akın, SE; Bacanak, BN; Kaya, O; Ozcan, MS; Pekbay, B; Temel, EN; Turk, O; Unal, O; Yilmaz, GR; Yirmibes, EOB; Yurekli, VA1
Aram, JA; Cao, G; Cornely, OA; Desai, A; Fayyad, R; Guo, X; Hamed, K; Wu, D; Zhang, J; Zhang, Y1
Ishii, T; Okuma, M; Tanaka, H1
Fujii, S; Hamada, Y; Hanai, Y; Kimura, T; Matsumoto, K; Mayumi, T; Miyazaki, Y; Oda, K; Takahashi, Y; Takesue, Y; Ueda, T1
Barbeito Castiñeiras, G; Bardán García, B; Belles Medall, D; Blanco Hortas, A; Blanco-Dorado, S; Campos-Toimil, M; Carracedo, Á; Durán Piñeiro, G; Fernández-Ferreiro, A; Gómez Márquez, A; Lamas, MJ; Latorre-Pellicer, A; López-Vizcaíno, A; Maroñas, O; Otero Espinar, F; Pérez Del Molino Bernal, ML; Rodríguez Jato, MT; Zarra Ferro, I1
Aram, JA; Freivogel, K; Lem, J; Lewis, A; Moosavi, S; Sobel, RE; Younus, M1
Battistella, M; Hamandi, B; Husain, S; Lee, J; Lefebvre, MJ; Ng, P1
Alharbi, AF; Fisher, J; Jacobson, PA; Kirstein, MN; Rubin, NT; Smith, AR; Takahashi, T1
Aoki, Y; Chandler, RE; Lönnstedt, IM; Wakao, R1
Brandi, SL; Eldrup, E; Feltoft, CL; Serup, J1
Dryś, A; Dybko, J; Hurkacz, M; Sienkiewicz, B; Urbaniak-Kujda, D; Wiela-Hojeńska, A; Wróbel, T1
Assaf, A; Chaftari, AM; Hachem, R; Jiang, Y; Numan, Y; Raad, II; Shah, P1
Bertaccini, P; Castagnetti, F; Cavo, M; Faccioli, L; Lewis, RE; Paolucci, M; Primavera, L; Rizzello, I; Spinardi, L; Stanzani, M; Toschi, PG1
Bes, D; Lede, R; Rosanova, MT; Sberna, N; Serrano Aguilar, P1
Hussain, S1
Bongomin, F; Felton, T; Maguire, N; Moore, CB; Rautemaa-Richardson, R1
Aram, JA; Lee, DG; Lee, HJ; Lin, SS; Yan, JL1
Dolton, MJ; McLachlan, AJ1
Chandrasekar, P; Patel, D; Rupali, P1
Boix, H; Camba Longueira, F; Frick, MA; Martin-Gomez, MT; Rodrigo-Pendás, JÁ; Soler-Palacin, P1
Agúndez, J; Barbarino, J; Caudle, KE; Cross, SJ; Henning, SA; Klein, TE; McLeod, HL; Moriyama, B; Obeng, AO; Penzak, SR; Scott, SA; Walsh, TJ; Wingard, JR1
Cai, S; Cao, C; Liang, H; Ouyang, Y1
Anna, WH; Beata, S; Donata, UK; Jarosław, D; Tomasz, W1
Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S1
Allenet, B; Auzéric, M; Bedouch, P; Bellemère, J; Charpiat, B; Conort, O; Juste, M; Rose, FX; Roubille, R1
Christen, S; Egger, SS; Gratwohl, A; Haschke, M; Krähenbühl, S; Leu, C; Meier, S1
George, J; Reboli, AC1
Aoun, M; Gadisseur, A; Jacobs, F; Selleslag, D; Sonet, A1
Gray, C; Labois, A; Lepretre, S1
de Heredia, CD; Figueras, C; Frick, MA; Lanaspa, M; Martín-Nalda, A; Pou, L; Roselló, E; Soler-Palacín, P1
Auzinger, G; Borges Sá, M; Dimopoulos, G; Grigoras, I; Kantecki, M; Marček, T; Meersseman, W; Menichetti, F; Miller, PJ; Montravers, P; Pachl, J; Paiva, JA; Ruhnke, M; Sganga, G1
Blyth, CC; Cole, C; Gottardo, NG; Hansford, JR1
Ieda, M; Kobayashi, D; Ohshima, S; Yamamoto, M1
Bergeron, A; Bergot, E; Bourdin, A; Cadranel, J; Cottin, V; Germaud, P; Godet, C; Hennequin, C; Jeanfaivre, T; Philippe, B; Pineau, M1

Reviews

7 review(s) available for voriconazole and Adverse Drug Event

ArticleYear
Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal disease.
    Future microbiology, 2022, Volume: 17

    Topics: Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Healthy Volunteers; Humans; Invasive Fungal Infections; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole

2022
Clinical Practice Guideline for the Therapeutic Drug Monitoring of Voriconazole in Non-Asian and Asian Adult Patients: Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
    Clinical therapeutics, 2022, Volume: 44, Issue:12

    Topics: Adult; Antifungal Agents; Chemical and Drug Induced Liver Injury; Consensus; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; East Asian People; Humans; Voriconazole

2022
Effect of Therapeutic Drug Monitoring and Cytochrome P450 2C19 Genotyping on Clinical Outcomes of Voriconazole: A Systematic Review.
    The Annals of pharmacotherapy, 2021, Volume: 55, Issue:4

    Topics: Antifungal Agents; Cytochrome P-450 CYP2C19; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Genotype; Humans; Polymorphism, Genetic; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; Voriconazole

2021
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia.
    Mycoses, 2018, Volume: 61, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Female; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2018
Efficacy and safety of voriconazole in immunocompromised patients: systematic review and meta-analysis.
    Infectious diseases (London, England), 2018, Volume: 50, Issue:7

    Topics: Adolescent; Antifungal Agents; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Voriconazole; Young Adult

2018
Voriconazole pharmacokinetics and exposure-response relationships: assessing the links between exposure, efficacy and toxicity.
    International journal of antimicrobial agents, 2014, Volume: 44, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Humans; Treatment Failure; Voriconazole

2014
Anidulafungin: when and how? The clinician's view.
    Mycoses, 2012, Volume: 55, Issue:1

    Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012

Trials

3 trial(s) available for voriconazole and Adverse Drug Event

ArticleYear
Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis.
    Mycoses, 2019, Volume: 62, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Asian People; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Placebos; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult

2019
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Invasive; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Endoscopy; Female; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2012

Other Studies

28 other study(ies) available for voriconazole and Adverse Drug Event

ArticleYear
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    PLoS computational biology, 2011, Volume: 7, Issue:12

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests

2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
N,N'-diaryl-bishydrazones in a biphenyl platform: Broad spectrum antifungal agents.
    European journal of medicinal chemistry, 2019, Feb-15, Volume: 164

    Topics: Animals; Antifungal Agents; Biphenyl Compounds; Drug-Related Side Effects and Adverse Reactions; Erythrocytes; Fungicides, Industrial; Hemolysis; Hydrazones; Mice

2019
Association between voriconazole exposure and Sequential Organ Failure Assessment (SOFA) score in critically ill patients.
    PloS one, 2021, Volume: 16, Issue:11

    Topics: Antifungal Agents; Critical Illness; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; France; Humans; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Risk Factors; Voriconazole

2021
A rare side effect due to voriconazole: myasthenia gravis.
    European journal of clinical pharmacology, 2022, Volume: 78, Issue:8

    Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Myasthenia Gravis; Voriconazole

2022
Occurrence of voriconazole-induced cutaneous squamous cell carcinoma in Japan: data mining from different national pharmacovigilance databases.
    Die Pharmazie, 2022, 10-01, Volume: 77, Issue:10

    Topics: Adverse Drug Reaction Reporting Systems; Carcinoma, Squamous Cell; Data Mining; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Epithelial Cells; Humans; Japan; Pharmacovigilance; Skin Neoplasms; Voriconazole

2022
Impact of CYP2C19 Genotype and Drug Interactions on Voriconazole Plasma Concentrations: A Spain Pharmacogenetic-Pharmacokinetic Prospective Multicenter Study.
    Pharmacotherapy, 2020, Volume: 40, Issue:1

    Topics: Adult; Antifungal Agents; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Humans; Male; Mycoses; Prevalence; Prospective Studies; Spain; Voriconazole

2020
Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey.
    Pharmaceutical medicine, 2019, Volume: 33, Issue:2

    Topics: Antifungal Agents; Carcinoma, Squamous Cell; Checklist; Chemical and Drug Induced Liver Injury; Cross-Sectional Studies; Dermatitis, Phototoxic; Drug-Related Side Effects and Adverse Reactions; European Union; Health Care Surveys; Health Personnel; Humans; Invasive Pulmonary Aspergillosis; Mycoses; Pamphlets; Pharmacovigilance; Risk Reduction Behavior; Self Report; Skin Neoplasms; Voriconazole

2019
    International journal of clinical pharmacology and therapeutics, 2021, Volume: 59, Issue:6

    Topics: Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Drug-Related Side Effects and Adverse Reactions; Hematopoietic Stem Cell Transplantation; Humans; Sterol 14-Demethylase; Voriconazole

2021
The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan.
    Drug safety, 2021, Volume: 44, Issue:6

    Topics: Adverse Drug Reaction Reporting Systems; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Humans; Irinotecan; Japan; Voriconazole

2021
Pseudohyperaldosteroism during itraconazole treatment: a hitherto neglected clinically significant side effect.
    BMJ case reports, 2021, Jun-18, Volume: 14, Issue:6

    Topics: Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Itraconazole; Voriconazole

2021
Influence of CYP2C19 Genotypes on the Occurrence of Adverse Drug Reactions of Voriconazole among Hematological Patients after Allo-HSCT.
    Pathology oncology research : POR, 2018, Volume: 24, Issue:3

    Topics: Biomarkers, Tumor; Cohort Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A Inhibitors; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Genotype; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Polymorphism, Genetic; Prognosis; Transplantation, Homologous; Voriconazole

2018
Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies.
    International journal of antimicrobial agents, 2017, Volume: 50, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Hospitals, University; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Survival Analysis; Texas; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2017
Voriconazole-induced Severe Periostitis Deformans.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:6

    Topics: Aged; Antifungal Agents; Aspergillus; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Osteomyelitis; Periostitis; Voriconazole

2018
Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
    Mycoses, 2019, Volume: 62, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Retrospective Studies; Triazoles; United Kingdom; Voriconazole

2019
Voriconazole toxicity masquerading as septic shock.
    Leukemia & lymphoma, 2015, Volume: 56, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Shock, Septic; Voriconazole

2015
Primary Cutaneous Aspergillosis in a Preterm Infant.
    The Pediatric infectious disease journal, 2016, Volume: 35, Issue:6

    Topics: Antifungal Agents; Aspergillosis; Dermatomycoses; Drug-Related Side Effects and Adverse Reactions; Fatal Outcome; Humans; Infant, Newborn; Infant, Premature; Male; Multiple Organ Failure; Voriconazole

2016
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy.
    Clinical pharmacology and therapeutics, 2017, Volume: 102, Issue:1

    Topics: Antifungal Agents; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Genotyping Techniques; Humans; Metabolic Clearance Rate; Patient Selection; Pharmacogenomic Variants; Risk Assessment; Voriconazole

2017
Administration of Voriconazole in Disseminated Talaromyces (Penicillium) Marneffei Infection: A Retrospective Study.
    Mycopathologia, 2017, Volume: 182, Issue:5-6

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Female; Fungemia; HIV Infections; Humans; Infant; Male; Middle Aged; Retrospective Studies; Talaromyces; Treatment Outcome; Voriconazole; Young Adult

2017
Influence of CYP2C19*2/*17 genotype on adverse drug reactions of voriconazole in patients after allo-HSCT: a four-case report.
    Journal of cancer research and clinical oncology, 2017, Volume: 143, Issue:6

    Topics: Cytochrome P-450 CYP2C19; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Polymorphism, Genetic; Transplantation Conditioning; Transplantation, Homologous; Voriconazole

2017
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
    Therapeutic drug monitoring, 2009, Volume: 31, Issue:3

    Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2009
[Designing a tool to describe drug interactions and adverse events for learning and clinical routine].
    Annales pharmaceutiques francaises, 2009, Volume: 67, Issue:6

    Topics: Antifungal Agents; Audiovisual Aids; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Education, Pharmacy, Continuing; Immunosuppressive Agents; Leukocyte Count; Pharmacists; Pyrimidines; Software; Students, Pharmacy; Tacrolimus; Triazoles; Voriconazole

2009
Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT.
    Bone marrow transplantation, 2010, Volume: 45, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Prevalence; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2010
An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Survival Analysis; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012
Successful treatment of disseminated fusariosis with voriconazole in an acute lymphoblastic leukaemia patient.
    Mycoses, 2011, Volume: 54 Suppl 4

    Topics: Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography, Thoracic; Skin; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:3

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunocompromised Host; Incidence; Infant; Male; Mycoses; Plasma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:7

    Topics: Antifungal Agents; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Mycoses; Neoplasms; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole

2012
[Quantitative evaluation method of the informational value of initial symptoms based on Bayesian theory].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Volume: 132, Issue:6

    Topics: Antifungal Agents; Bayes Theorem; Chemical and Drug Induced Liver Injury; Drug Information Services; Drug-Related Side Effects and Adverse Reactions; Exanthema; Humans; Pharmacists; Probability; Pyrimidines; Symptom Assessment; Triazoles; Voriconazole

2012